PT  - JOURNAL ARTICLE
AU  - DeWayne Townsend IV
AU  - Philip S. Portoghese
AU  - David R. Brown
TI  - Characterization of Specific Opioid Binding Sites in Neural Membranes from the Myenteric Plexus of Porcine Small Intestine
AID  - 10.1124/jpet.103.058016
DP  - 2004 Jan 01
TA  - Journal of Pharmacology and Experimental Therapeutics
PG  - 385--393
VI  - 308
IP  - 1
4099  - http://jpet.aspetjournals.org/content/308/1/385.short
4100  - http://jpet.aspetjournals.org/content/308/1/385.full
SO  - J Pharmacol Exp Ther2004 Jan 01; 308
AB  - δ- and κ-Opioid receptors (OPRs), but not μ-OPRs, are expressed in the myenteric plexus of the porcine distal small intestine. In a subpopulation of myenteric neurons, δ- and κ-OPRs seem to be colocalized and may functionally interact. In this study, radioligand binding was used to characterize myenteric OPR populations in detail. The nonselective OPR antagonist [3H]diprenorphine bound to a single, high-affinity site in myenteric neural membrane homogenates. Naloxone displaced 65 and 59% of [3H]diprenorphine binding from this site in Na+-free Tris and Krebs-HEPES buffers, respectively. Naltrexone-derived δ- and κ-OPR antagonists, including naltriben, 7-benzylidenenaltrexone, nor-binaltorphimine, and 5′-guanidinonaltrindole, displaced [3H]diprenorphine from two distinct binding sites to levels similar to that of naloxone. The selective δ-OPR ligands Tyr-1,2,3,4-tetrahydroisoquinoline-Phe-Phe-OH (TIPP), [d-Pen2,d-Pen5]enkephalin (DPDPE), [d-Ala2, Glu4]deltorphin II, and (+)-4-[(αR)-α((2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl-3-methoxybenzyl)-N,N-diethylbenzamide (SNC-80) and the κ-OPR agonist (d-(5α,7α,8β)-(-)-N-methyl-N-(7-(1-pyrrolidinyl)-1-oxoaspiro-(4,5)dec-8-yl) benzeneacetamide (U-69,593) displaced [3H]diprenorphine from three independent binding sites; these included high-affinity δ- and κ-OPR sites, and a residual binding site. Residual [3H]diprenorphine binding was displaced by the selective κ-OPR antagonist nor-binaltorphimine after saturation of δ and κ sites, respectively, with DPDPE and U-69,593. The residual binding site displayed low affinity for δ- and κ-OPR agonists and TIPP, as well as moderate affinity for naltrexone-derived ligands, properties reminiscent of δ-/κ-OPR heterodimers. The American Society for Pharmacology and Experimental Therapeutics